Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday
There's Reason For Concern Over Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) Massive 61% Price Jump
Shareholders Have Faith in Loss-making Sangamo Therapeutics (NASDAQ:SGMO) as Stock Climbs 55% in Past Week, Taking One-year Gain to 221%
Truist Financial Maintains Sangamo Therapeutics(SGMO.US) With Hold Rating
TD Cowen Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating
A Quick Look at Today's Ratings for Sangamo Therapeutics(SGMO.US), With a Forecast Between $1 to $5
